Trial intelligence / Profile preview

Pilot randomized placebo-controlled crossover study of ripasudil eye drops for refractory macular edema associated with retinitis pigmentosa

MOH_2021-05-02_009933Phase 2Not yet recruiting

Sponsor
ד"ר אדוארד אברבוך
Start
Mar 2021
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 2, randomised trial of glatiramer acetate in macular edema (2 arms), sponsored by ד"ר אדוארד אברבוך. Planned start Mar 2021; status: not yet recruiting.

02

Drugs

glatiramer acetate
03

Conditions

macular edema

Beyond the preview

Go deeper on MOH_2021-05-02_009933.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on MOH_2021-05-02_009933.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call